Read + Share
Jin Y, Lin C, Shi X, He Q, et al. Impact of clinical and molecular features on efficacy and outcome of patients
with non-small cell lung cancer receiving second-line osimertinib. BMC Cancer 2022;22:586.
PMID: 35643428
|
 |
|
Jin Y, Lin C, Shi X, He Q, et al. Impact of clinical and molecular features on efficacy and outcome of patients
with non-small cell lung cancer receiving second-line osimertinib. BMC Cancer 2022;22:586.
PMID: 35643428
|
|
|
|